eyecbetter’s Post

Surendra Basti, MD, Manjot K. Gill, MD, and Angelo P. Tanna, MD, of Northwestern Medicine Ophthalmology, share what you need to know from AAO 2024. Listen to the full recap here: https://lnkd.in/eVDf-_xc

Healthcare cybersecurity has never been more critical, with the risks to patient safety and business continuity growing every day. At MyRxWallet, we understand the urgency of this challenge and are fully equipped to transform healthcare cybersecurity. Our blockchain-powered platform and tamper-proof technology ensure that patient data remains secure and immutable, virtually eliminating the threat of unauthorized access or data manipulation. With AI-driven monitoring, we offer real-time protection, detecting and neutralizing threats before they cause harm. By decentralizing data management through our Web3 infrastructure, we prevent single points of failure, dramatically reducing the risk of breaches that can compromise entire systems. At MyRxWallet, we’re not just meeting the moment; we’re redefining healthcare cybersecurity for the future. With our solutions, providers can focus on delivering care, knowing their systems and patient data are secure. Let’s build a safer, more resilient healthcare infrastructure—together. #Cybersecurity #HealthcareInnovation #Blockchain #AI #DataSecurity #Web3 #MyRxWallet #HealthcareTransformation

✨ Exciting News! ✨ I'm delighted to share the publication of my latest article titled "Shedding Light on Congenital Aniridia: An In-depth Study of Two Cases" in JFO Open Ophthalmology. This work explores the complexities of congenital aniridia through two detailed case studies, contributing valuable insights to the field of ophthalmology. I'm grateful to the editorial team and reviewers for their guidance throughout the publication process. A special thanks to my colleagues and mentors who supported this endeavour. I hope this article will serve as a helpful resource for clinicians and researchers interested in rare ocular conditions. 💻 Access the article here: https://lnkd.in/eDUs6Us5 #Ophthalmology #ResearchPublication #CongenitalAniridia #OcularGenetics #OpenAccess

This paper goes some way to addressing the question of “Why are doctors switching to faricimab?”

It is my pleasure to announce that our book in the field of glaucoma has recently been published. It is a practical book discussing, in illustrated form, the scientific approach to different cases of glaucoma . This is an educational book for ophthalmology residents and fellowships of glaucoma. Here is the link to the book https://lnkd.in/gcDgiXDP

Photobiomodulation use in Ophthalmology - an overview of translational research from bench to bedside

As we recognize #BrainAwarenessWeek, check out this interview with Shira Simon, MD, MBA, Director of Neuro-ophthalmology in the Dept. of Ophthalmology, as she discusses new research, clinical innovations, and what Northwestern Medicine is doing to elevate the Ophthalmology field.

Thanks to Dr. Rosetta Pietro for this opportunity and to Dr Gianmaria Barone and Francesco Santoru for their precious collaboration in publishing this study conducted at the Department of Ophthalmology, Humanitas San Pio X, Milan. The study evaluates the outcomes of transepithelial iontophoresis cross-linking (I-CXL) in managing early keratoconus in patients under 25. 📊 Key Findings: - **Patient Profile:** High visual acuity (LogMAR ≤ 0.2) and early keratoconus treated with I-CXL. - **Outcome Stability:** After a 24-month follow-up, no significant changes in key metrics such as CDVA, keratometry, or corneal thickness were observed. - **Safety and Effectiveness:** None of the patients exhibited keratoconus progression during the follow-up period. - **Potential Benefits:** I-CXL emerges as a minimally invasive option for less advanced patients, offering an alternative to standard epithelium-off CXL.

In the latest episode of Science@UH, Daniel Simon,MD, and renowned ophthalmologist Jonathan Lass, MD, explore groundbreaking innovations in eye care from pioneering reading centers to advances in corneal transplants and treatments for macular degeneration. Learn more about the future of ophthalmology and how clinical research is shaping new therapeutic solutions for eye diseases at https://bit.ly/3XBfZY2

Advanced Age Linked to TED Retreatment, Uveal Melanoma Pigmentation Linked to Poor ...: Key findings from Ophthalmology, Ophthalmology Retina, Ophthalmology Science, AJO, JAMA Ophthalmology, and more. http://dlvr.it/TH6lwv